TrialFrontiers in immunology2023

Study of efficacy and antibody duration to fourth-dose booster of Ad5-nCoV or inactivated SARS-CoV-2 vaccine in Chinese adults: a prospective cohort study.

Nani Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.